Treatment with esketamine combined with an SNRI is linked to fewer adverse outcomes than treatment with an SSRI alone.

Methylene blue has gained widespread attention for its potential effects on focus, mood, and energy. Originally developed as a dye, researchers have since discovered its unique physiological benefits.

milnacipran, mirtazapine, rasagiline, selegiline, trazodone, tryptophan, and St. John’s wort, among other medications and supplements. Researchers have studied methylene blue since the 1880s. Over the ...

These include: Cymbalta (duloxetine), a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant Lyrica (pregabalin), an anticonvulsant (anti-seizure medication) that treats nerve pain ...

Clinical Rheumatology. 2009 Sep;28(9):1035-44. Derry S, et al. Milnacipran for Neuropathic Pain and Fibromyalgia in Adults. Cochrane Database of Systematic Reviews. 2012 Mar 14;3:CD008244. Nishiyori M ...

Antidepressant discontinuation syndrome can cause symptoms such as nausea, headaches, diarrhea, or even reoccurrence of ...

Tonix Pharmaceuticals has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. Despite positive pivotal study data, Tonix faces significant ...